In vitro Activity of Contezolid Against Methicillin-Resistant Staphylococcus aureus, Vancomycin-Resistant Enterococcus, and Strains With Linezolid Resistance Genes From China

Contezolid is a novel oxazolidinone, which exhibits potent activity against gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE), and penicillin-resistant Streptococcus pneumoniae (PRSP). In this study, the in vitro activity of...

Full description

Bibliographic Details
Main Authors: Siheng Wang, Chang Cai, Yingbo Shen, Chengtao Sun, Qingxin Shi, Ningjun Wu, Shufang Zheng, Jiao Qian, Rong Zhang, Hongwei Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2021.729900/full
_version_ 1818577176161681408
author Siheng Wang
Chang Cai
Yingbo Shen
Chengtao Sun
Qingxin Shi
Ningjun Wu
Shufang Zheng
Jiao Qian
Rong Zhang
Hongwei Zhou
author_facet Siheng Wang
Chang Cai
Yingbo Shen
Chengtao Sun
Qingxin Shi
Ningjun Wu
Shufang Zheng
Jiao Qian
Rong Zhang
Hongwei Zhou
author_sort Siheng Wang
collection DOAJ
description Contezolid is a novel oxazolidinone, which exhibits potent activity against gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE), and penicillin-resistant Streptococcus pneumoniae (PRSP). In this study, the in vitro activity of contezolid was compared with linezolid (LZD), tigecycline (TGC), teicoplanin (TEC), vancomycin (VA), daptomycin (DAP), and florfenicol (FFC) against MRSA and VRE strains isolated from China. Contezolid revealed considerable activity against MRSA and VRE isolates with MIC90 values of 0.5 and 1.0 μg/mL, respectively. For VRE strains with different resistance genotypes, including vanA- and vanM-type strains, contezolid did not exhibit significantly differential antibacterial activity. Furthermore, the antimicrobial activity of contezolid is similar to or slightly better than that of linezolid against MRSA and VRE strains. Subsequently, the activity of contezolid was tested against strains carrying linezolid resistance genes, including Staphylococcus capitis carrying cfr gene and Enterococcus faecalis carrying optrA gene. The results showed that contezolid exhibited similar antimicrobial efficacy to linezolid against strains with linezolid resistance genes. In general, contezolid may have potential benefits to treat the infections caused by MRSA and VRE pathogens.
first_indexed 2024-12-16T06:25:45Z
format Article
id doaj.art-008bd330979f49a08d81568384f2a3c2
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-12-16T06:25:45Z
publishDate 2021-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-008bd330979f49a08d81568384f2a3c22022-12-21T22:41:00ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2021-08-011210.3389/fmicb.2021.729900729900In vitro Activity of Contezolid Against Methicillin-Resistant Staphylococcus aureus, Vancomycin-Resistant Enterococcus, and Strains With Linezolid Resistance Genes From ChinaSiheng Wang0Chang Cai1Yingbo Shen2Chengtao Sun3Qingxin Shi4Ningjun Wu5Shufang Zheng6Jiao Qian7Rong Zhang8Hongwei Zhou9Clinical Microbiology Laboratory, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, ChinaChina Australia Joint Laboratory for Animal Health Big Data Analytics, College of Animal Science and Technology, Zhejiang Agricultural and Forestry University, Hangzhou, ChinaBeijing Advanced Innovation Center for Food Nutrition and Human Health, College of Veterinary Medicine, China Agricultural University, Beijing, ChinaBeijing Advanced Innovation Center for Food Nutrition and Human Health, College of Veterinary Medicine, China Agricultural University, Beijing, ChinaClinical Laboratory Department, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, ChinaClinical Laboratory, Lishui People’s Hospital, Lishui, ChinaDepartment of Laboratory Medicine, Jinhua People’s Hospital, Jinhua, ChinaClinical Laboratory Department, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, ChinaClinical Microbiology Laboratory, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, ChinaClinical Microbiology Laboratory, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, ChinaContezolid is a novel oxazolidinone, which exhibits potent activity against gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE), and penicillin-resistant Streptococcus pneumoniae (PRSP). In this study, the in vitro activity of contezolid was compared with linezolid (LZD), tigecycline (TGC), teicoplanin (TEC), vancomycin (VA), daptomycin (DAP), and florfenicol (FFC) against MRSA and VRE strains isolated from China. Contezolid revealed considerable activity against MRSA and VRE isolates with MIC90 values of 0.5 and 1.0 μg/mL, respectively. For VRE strains with different resistance genotypes, including vanA- and vanM-type strains, contezolid did not exhibit significantly differential antibacterial activity. Furthermore, the antimicrobial activity of contezolid is similar to or slightly better than that of linezolid against MRSA and VRE strains. Subsequently, the activity of contezolid was tested against strains carrying linezolid resistance genes, including Staphylococcus capitis carrying cfr gene and Enterococcus faecalis carrying optrA gene. The results showed that contezolid exhibited similar antimicrobial efficacy to linezolid against strains with linezolid resistance genes. In general, contezolid may have potential benefits to treat the infections caused by MRSA and VRE pathogens.https://www.frontiersin.org/articles/10.3389/fmicb.2021.729900/fullcontezolidmethicillin-resistant Staphylococcus aureusvancomycin-resistant Enterococcuslinezolidantibioticsantimicrobial activity
spellingShingle Siheng Wang
Chang Cai
Yingbo Shen
Chengtao Sun
Qingxin Shi
Ningjun Wu
Shufang Zheng
Jiao Qian
Rong Zhang
Hongwei Zhou
In vitro Activity of Contezolid Against Methicillin-Resistant Staphylococcus aureus, Vancomycin-Resistant Enterococcus, and Strains With Linezolid Resistance Genes From China
Frontiers in Microbiology
contezolid
methicillin-resistant Staphylococcus aureus
vancomycin-resistant Enterococcus
linezolid
antibiotics
antimicrobial activity
title In vitro Activity of Contezolid Against Methicillin-Resistant Staphylococcus aureus, Vancomycin-Resistant Enterococcus, and Strains With Linezolid Resistance Genes From China
title_full In vitro Activity of Contezolid Against Methicillin-Resistant Staphylococcus aureus, Vancomycin-Resistant Enterococcus, and Strains With Linezolid Resistance Genes From China
title_fullStr In vitro Activity of Contezolid Against Methicillin-Resistant Staphylococcus aureus, Vancomycin-Resistant Enterococcus, and Strains With Linezolid Resistance Genes From China
title_full_unstemmed In vitro Activity of Contezolid Against Methicillin-Resistant Staphylococcus aureus, Vancomycin-Resistant Enterococcus, and Strains With Linezolid Resistance Genes From China
title_short In vitro Activity of Contezolid Against Methicillin-Resistant Staphylococcus aureus, Vancomycin-Resistant Enterococcus, and Strains With Linezolid Resistance Genes From China
title_sort in vitro activity of contezolid against methicillin resistant staphylococcus aureus vancomycin resistant enterococcus and strains with linezolid resistance genes from china
topic contezolid
methicillin-resistant Staphylococcus aureus
vancomycin-resistant Enterococcus
linezolid
antibiotics
antimicrobial activity
url https://www.frontiersin.org/articles/10.3389/fmicb.2021.729900/full
work_keys_str_mv AT sihengwang invitroactivityofcontezolidagainstmethicillinresistantstaphylococcusaureusvancomycinresistantenterococcusandstrainswithlinezolidresistancegenesfromchina
AT changcai invitroactivityofcontezolidagainstmethicillinresistantstaphylococcusaureusvancomycinresistantenterococcusandstrainswithlinezolidresistancegenesfromchina
AT yingboshen invitroactivityofcontezolidagainstmethicillinresistantstaphylococcusaureusvancomycinresistantenterococcusandstrainswithlinezolidresistancegenesfromchina
AT chengtaosun invitroactivityofcontezolidagainstmethicillinresistantstaphylococcusaureusvancomycinresistantenterococcusandstrainswithlinezolidresistancegenesfromchina
AT qingxinshi invitroactivityofcontezolidagainstmethicillinresistantstaphylococcusaureusvancomycinresistantenterococcusandstrainswithlinezolidresistancegenesfromchina
AT ningjunwu invitroactivityofcontezolidagainstmethicillinresistantstaphylococcusaureusvancomycinresistantenterococcusandstrainswithlinezolidresistancegenesfromchina
AT shufangzheng invitroactivityofcontezolidagainstmethicillinresistantstaphylococcusaureusvancomycinresistantenterococcusandstrainswithlinezolidresistancegenesfromchina
AT jiaoqian invitroactivityofcontezolidagainstmethicillinresistantstaphylococcusaureusvancomycinresistantenterococcusandstrainswithlinezolidresistancegenesfromchina
AT rongzhang invitroactivityofcontezolidagainstmethicillinresistantstaphylococcusaureusvancomycinresistantenterococcusandstrainswithlinezolidresistancegenesfromchina
AT hongweizhou invitroactivityofcontezolidagainstmethicillinresistantstaphylococcusaureusvancomycinresistantenterococcusandstrainswithlinezolidresistancegenesfromchina